CytoDyn Inc.

  • Home
  • About
    • Overview
    • Our Mission
  • Our Team
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Join our Team
  • Our Science
  • Pipeline
  • FAQs
  • Newsroom
  • Publications
  • Investor Relations
    • Overview
    • FAQs
    • Investor Update Calls
    • Annual Meeting of Stockholders
    • Warrant Exercise Inquiries
    • Restricted Stock Inquiries
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact
Site Announcement

For the latest results and updates on our Phase 2 CRC trial and more, here’s a direct link to our October 19, 2026 Investor Update Webinar

Learn More

Newsroom

  • All
  • Press Releases
  • Videos
  • Presentations

ESMO Congress 2026 | Leronlimab Shows Early ctDNA and Safety Signals in Metastatic Colorectal Cancer

Oct 25, 2026
Videos

Life Sciences Virtual Investor Forum Presentation (Robert Hoffman)

Sep 17, 2026
Videos

Guest Appearance on The Big Biz Show (Dr. Jacob Lalezari)

Jun 24, 2026
Videos

LD Micro Conference Presentation (Robert Hoffman)

May 18, 2026
Videos

HC Wainwright Conference Presentation (Robert Hoffman)

Sep 10, 2025 6:00am PDT
Videos

ESMO GI 2025 | Targeting CCR5 with leronlimab in colorectal cancer

Jul 18, 2025
Videos
RSS
© 2026 CytoDyn Inc. All Rights Reserved.
Privacy Policy Legal Notice & Disclaimer Sitemap